PBMs Are Taking Action to Promote Patient Access to Prescription Drugs During the COVID-19 Pandemic

  To help facilitate access to our nation’s nearly 70,000 retail pharmacies, PBMs are actively providing information to RxOpen, a central hub created after Hurricane Katrina to help promote uniform, consistent supply-chain information for stakeholders. PBMs also are supporting policy solutions that ease operational barriers and help empower pharmacy professionals to support our nation’s COVID-19...

Keep Reading

New Study: Pharmacy Benefit Managers (PBMs): The Return on Investment (ROI) on PBM Services

Pharmacy benefit managers (PBMs) save consumers and payers an average of $962 per person, per year, which is a $21 increase from 2016.  Research by Visante – which was commissioned by the Pharmaceutical Care Management Association (PCMA) also highlights PBMs’ role in reducing medication errors and improving patients’ health through increased adherence rates and specialty...

Keep Reading

Podcasts

Keep Reading

PCMA President and CEO Mark Merritt to Depart At Year-End

(Washington, D.C.) — After 15 years at the helm of the Pharmaceutical Care Management Association (PCMA), CEO and President Mark Merritt is stepping down, effective at year-end. Under Merritt’s leadership, PCMA grew from an obscure group into the nation’s leading voice on prescription drug benefits.  One of his first missions was to help shape the...

Keep Reading

The Return on Investment (ROI) on PBM Services

An analysis from Visante quantifying how PBMs generate $6 in savings for each $1 spent on their services. Major Findings Pharmacy benefit managers (PBMs) will help reduce prescription drug costs for more than 266 million Americans in 2017. PBMs save payers and patients 40-50% on their annual prescription drug and related medical costs compared to...

Keep Reading

Mostafa Kamal

Chief Executive Officer Magellan Rx Management As chief executive officer of Magellan Rx Management, Mostafa Kamal is responsible for all of Magellan’s pharmacy business lines, including the commercial, government and specialty pharmacy divisions. He leads the strategy, operations, growth and profitability of Magellan Rx Management with the overarching goal of delivering innovative, best-in-class drug management...

Keep Reading

How Copay Coupons Could Raise Prescription Drug Costs By $32 Billion Over the Next Decade

Much has been much written about the strategies that brand drug companies will use to combat the “generic wave” of medications becoming available. One answer can be found in the “copay coupon” marketing campaigns now flooding the marketplace. Much is at stake, as each one percentage point decrease in the generic drug dispensing rate raises...

Keep Reading

PCMA Launches Campaign: ‘That’s What PBMs Do’

  (Washington, DC) — The Pharmaceutical Care Management Association (PCMA) today launched a new ad campaign – “That’s What PBMs Do” – that highlights the core value proposition of pharmacy benefit managers (PBMs). The ad campaign focuses on key themes including: PBMs reduce pharmacy costs for employers, unions, and consumers PBMs play a key role...

Keep Reading

Brand Drug ‘Copay Coupons’ Raise Health Costs for Employers, Unions, and State Governments by $32 Billion

  (Washington, DC)— Prescription copay coupon marketing programs, which lure insured consumers away from generics and toward more expensive brands, will increase costs by $32 billion over the next decade, according to new research from Visante and released today by the Pharmaceutical Care Management Association (PCMA). Drug companies now offer “copay coupons” to undermine efforts...

Keep Reading

New Research: How Copay Coupons Could Raise Prescription Drug Costs By $32 Billion Over the Next Decade

  Much has been much written about the strategies that brand drug companies will use to combat the “generic wave” of medications becoming available. One answer can be found in the “copay coupon” marketing campaigns now flooding the marketplace. Much is at stake, as each one percentage point decrease in the generic drug dispensing rate...

Keep Reading